Physician profile
James Patrick Dilworth
NPI 1003813296
$971.64
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $122 · 2021: $15.44 · 2023: $25.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $327.33 | 2019-2020 | |
| Abbvie INC. | $121.25 | 2019-2023 | Qulipta |
| Ferring Pharmaceuticals INC. | $64.74 | 2019 | |
| Boston Scientific Corporation | $62.22 | 2019-2021 | |
| Olympus America INC. | $57.74 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $54.89 | 2019 | |
| Neotract INC. | $43.75 | 2019-2020 | |
| Janssen Biotech, INC. | $32.40 | 2019 | |
| Pfizer INC. | $28.00 | 2019-2020 | |
| Zyla Life Sciences, INC. | $24.09 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $23.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.90 | 2019 | |
| Mission Pharmacal Company | $20.53 | 2019 | |
| Blue Earth Diagnostics | $20.03 | 2019 | |
| Cook Medical LLC | $17.59 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $13.86 | 2019 | |
| Medtronic USA, INC. | $13.69 | 2019 | |
| Duchesnay USA Incorporated | $11.91 | 2019 | |
| Coloplast Corp | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dilworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.